Subscribe To
RPHM / Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop

RPHM News

By Seeking Alpha
October 29, 2023
Reneo Pharmaceuticals: Buy Before Upcoming Pivotal Data Drop
Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavodelpar or REN001. Mavodelpar has shown promising more_horizontal

By GlobeNewsWire
September 6, 2022
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the more_horizontal